CM
CM Management Portfolio holdings
AUM
$157M
Turnover
30.95%
1-Year Est. Return
60.08%
This Fund
S&P 500
This Quarter
Est. Return
+16.31%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$26.7M
(+25%)
Cap. Flow
+$13.4M
Cap. Flow
% of AUM
9.95%
Top 10 Holdings %
Top 10 Hldgs %
35.95%
Holding
101
New
21
Increased
28
Reduced
9
Closed
20
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amicus Therapeutics
FOLD
|
+$5.57M |
| 2 |
Alico
ALCO
|
+$2.28M |
| 3 |
Elicio Therapeutics
ELTX
|
+$1.81M |
| 4 |
Exelixis
EXEL
|
+$1.81M |
| 5 |
Merck
MRK
|
+$1.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aterian
ATER
|
+$7.86M |
| 2 |
Aviat Networks
AVNW
|
+$3.95M |
| 3 |
ClearPoint Neuro
CLPT
|
+$3.34M |
| 4 |
Intel
INTC
|
+$2.49M |
| 5 |
Gilead Sciences
GILD
|
+$1.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.52% |
| 2 | Financials | 13.92% |
| 3 | Technology | 12.69% |
| 4 | Energy | 10.02% |
| 5 | Materials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AVTA
26
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.66M | 1.24% |
100,000
| – | – |
2020 Q4
1 quarter
|
|
27
DELISTED
Southwestern Energy Company
SWN
| $1.63M | 1.21% |
350,000
+150,000
| +75% | +$606K |
2020 Q4
1 quarter
|
|
28
First Financial Corp
THFF
$868M
| $1.62M | 1.2% |
36,000
+8,000
| +29% | +$340K |
2020 Q4
1 quarter
|
|
29
National Healthcare
NHC
$3.67B
| $1.56M | 1.16% |
+20,000
| New | +$1.42M |
2021 Q1
0 quarters
|
|
30
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.55M | 1.15% |
258,565
| – | – |
2020 Q4
1 quarter
|
|
31
Energy Transfer Partners
ET
$69.7B
| $1.54M | 1.14% |
200,000
+60,000
| +43% | +$438K |
2020 Q4
1 quarter
|
|
32
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.49M | 1.11% |
6,000
+4,000
| +200% | +$858K |
2020 Q4
1 quarter
|
|
33
Barrick Mining
B
$64B
| $1.49M | 1.1% |
75,000
+35,000
| +88% | +$754K |
2020 Q4
1 quarter
|
|
34
Bristow Group
VTOL
$1.17B
| $1.37M | 1.02% |
53,000
| – | – |
2020 Q4
1 quarter
|
|
35
BioCardia
BCDA
$14M
| $1.36M | 1.01% |
20,873
+5,540
| +36% | +$346K |
2020 Q4
1 quarter
|
|
36
Alkermes
ALKS
$6.56B
| $1.31M | 0.97% |
+70,000
| New | +$1.43M |
2021 Q1
0 quarters
|
|
37
Battalion Oil
BATL
$59M
| $1.31M | 0.97% |
120,000
-10,000
| -8% | -$102K |
2020 Q4
1 quarter
|
|
38
ARKO Corp
ARKO
$453M
| $1.29M | 0.96% |
+130,000
| New | +$1.21M |
2021 Q1
0 quarters
|
|
39
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $1.29M | 0.96% |
300,000
-50,000
| -14% | -$216K |
2020 Q4
1 quarter
|
|
40
Bristol-Myers Squibb
BMY
$121B
| $1.26M | 0.94% |
+20,000
| New | +$1.24M |
2021 Q1
0 quarters
|
|
41
Amgen
AMGN
$230B
| $1.24M | 0.92% |
+5,000
| New | +$1.19M |
2021 Q1
0 quarters
|
|
42
SiriusXM
SIRI
$8.94B
| $1.22M | 0.91% |
+20,000
| New | +$1.22M |
2021 Q1
0 quarters
|
|
43
The Kraft Heinz Company
KHC
$26.9B
| $1.2M | 0.89% |
30,000
+20,000
| +200% | +$720K |
2020 Q4
1 quarter
|
|
44
PTC Therapeutics
PTCT
$4.98B
| $1.18M | 0.88% |
25,000
| – | – |
2020 Q4
1 quarter
|
|
|
45
Aterian
ATER
$10.7M
| $1.18M | 0.88% |
3,333
-20,417
| -86% | -$7.86M |
2020 Q4
1 quarter
|
|
46
Tejon Ranch
TRC
$438M
| $1.17M | 0.87% |
70,000
| – | – |
2020 Q4
1 quarter
|
|
47
CVS Health
CVS
$116B
| $1.13M | 0.84% |
15,000
| – | – |
2020 Q4
1 quarter
|
|
|
UFS
48
DELISTED
DOMTAR CORPORATION (New)
UFS
| $1.11M | 0.82% |
30,000
| – | – |
2020 Q4
1 quarter
|
|
49
Coherus Oncology
CHRS
$162M
| $1.1M | 0.81% |
75,000
+15,000
| +25% | +$255K |
2020 Q4
1 quarter
|
|
50
SandRidge Energy
SD
$521M
| $1.09M | 0.81% |
280,000
| – | – |
2020 Q4
1 quarter
|
|
Similar funds
SFSG
PTFIS
AWMG
LDNAM
DFS
APW
GA
TC
CM Management's Q1 2021 Portfolio in Review
As of Q1 2021, CM Management held 101 positions worth $135M, up 25% from $108M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
CM Management deployed $13.4M of net new capital in Q1 2021, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Elicio Therapeutics: 9,375 shares worth $1.69M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Aterian, an estimated $7.86M trimmed.
- CM Management's largest Q1 2021 buy was Elicio Therapeutics: 9,375 shares worth $1.69M.
- CM Management added most to Amicus Therapeutics in Q1 2021, an estimated $5.57M increase.
- CM Management's biggest Q1 2021 reduction was Aterian, cutting an estimated $7.86M.
- CM Management fully exited Aviat Networks in Q1 2021, selling an estimated $3.95M.
- CM Management's ten largest holdings make up 36% of its $135M portfolio in Q1 2021.
- CM Management opened 21 new positions and closed 20 in Q1 2021.
- CM Management's portfolio value rose 25% quarter-over-quarter to $135M.
Based on CM Management's 13F filing for Q1 2021, filed 12 May 2021.